Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios
Asset Utilization RatioAssets AverageDebt RatioDebt to EquityEBIT MarginEBITDA MarginEBT MarginEnterprise ValueEquity AverageEquity RatioFCF MarginInterest Coverage RatioInvested CapitalNet MarginOperating MarginReturn on AssetsReturn on Capital EmployedReturn on EquityReturn on Invested CapitalReturn on SalesTimes Interest Earned

Ironwood Pharmaceuticals (IRWD) FCF Margin (2016 - 2025)

Ironwood Pharmaceuticals (IRWD) has disclosed FCF Margin for 16 consecutive years, with 156.31% as the latest value for Q4 2025.

  • Quarterly FCF Margin rose 13951.0% to 156.31% in Q4 2025 from the year-ago period, while the trailing twelve-month figure was 42.89% through Dec 2025, up 1346.0% year-over-year, with the annual reading at 42.89% for FY2025, 1346.0% up from the prior year.
  • FCF Margin hit 156.31% in Q4 2025 for Ironwood Pharmaceuticals, up from 38.98% in the prior quarter.
  • In the past five years, FCF Margin ranged from a high of 156.31% in Q4 2025 to a low of 17.68% in Q2 2025.
  • Historically, FCF Margin has averaged 52.03% across 5 years, with a median of 51.72% in 2021.
  • Biggest YoY gain for FCF Margin was 13951bps in 2025; the steepest drop was -5307bps in 2025.
  • Year by year, FCF Margin stood at 55.02% in 2021, then skyrocketed by 34bps to 73.89% in 2022, then plummeted by -59bps to 30.3% in 2023, then plummeted by -45bps to 16.8% in 2024, then skyrocketed by 830bps to 156.31% in 2025.
  • Business Quant data shows FCF Margin for IRWD at 156.31% in Q4 2025, 38.98% in Q3 2025, and 17.68% in Q2 2025.